Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-21

FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Venlafaxine (venlafaxine hydrochloride) from BluePoint Laboratories, confirming the approval of a generic Venlafaxin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)